Alectinib is one of the "tinib" Tyrosine-kinase inhibitors. It is an oral drug that blocks the activity of anaplastic lymphoma kinase (ALK) and is used to treat non-small-cell lung cancer (NSCLC). It was developed by Chugai Pharmaceutical Co. Japan.
Generic name: n/a
Brand name: Alecensa
Therap-Cat: anti-cancer
Brand name: Alecensa
Therap-Cat: anti-cancer
Indications, Side Effects, Warnings Consumer Information of Alectinib please refer to: www.drugs.com
Chemical information of Alectinib:
List of manufacturers approved for Generic Alectinib:
n/a
List of manufacturers applied DMF for Alectinib: (by June 2017, data from www.fda.gov):
n/a
Manufacturers of Alectinib in China (data from www.sfda.gov.cn):
n/a
Intermediates of Alectinib:
1. CAS# 1256578-99-0 : 6-bromo-7-methoxy-1,1-dimethyl-3,4-dihydronaphthalen-2(1H)-one
Manufacturers of Alectinib intermediates:
Chemical name:
- 9-Ethyl-6,6-dimethyl-8-[4-(morpholin-4-yl)piperidin-1-yl]-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile
CAS#: 1256580-46-7
Chemical structure:


1. CAS# 1256578-99-0 : 6-bromo-7-methoxy-1,1-dimethyl-3,4-dihydronaphthalen-2(1H)-one
2. CAS# 4133-34-0: 3,4-Dihydro-7-methoxy-2(1H)-naphthalenone
3. CAS# 1256579-06-2: 9-Bromo-8-hydroxy-6,6-dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile
4. CAS# 120983-72-4: 1-chloro-1-chloroacetylcyclopropane;
5. CAS# 17672-26-3: 3-hydrazinylbenzonitrile
1. Zhejiang Ausun
2. Tianjin Reliable Pharmatech
......
* For detailed information or contact information of posaconazole manufacturers, please leave message or send email to: michaelapci@gmail.com